IP Library › Granted Patent US 11,655,457
Granted Patent B2
US 11,655,457 · App. 17/830,794 · Granted May 23, 2023

Methods of enhancing the sialic acid content of a CHO-expressed recombinant glycoprotein

Inventor: Jun Tian (Westford, MA)
Assignee: Bristol-Myers Squibb Company
C12N5/0682C12N5/0031C12P21/005C12N2500/22C12N2500/24C12N2500/32C12N2510/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,655,457
App. No.
17/830,794
Granted
May 23, 2023
Kind
B2
Abstract

In accordance with the present invention, CHO cells expressing a recombinant polypeptide of interest are grown in media where the amino acids, vitamins, phosphate, lipids and/or antioxidant optimization is utilized to manipulate and/or control the protein quality attributes of the polypeptides. Polypeptides expressed in accordance with the present invention may be advantageously used in the preparation of pharmaceutical compositions.

Claims (15)

1. A method of increasing sialic acid content of a recombinant glycoprotein expressed in Chinese Hamster Ovary (CHO) cells under suitable cell culture conditions comprising:

a) transfecting CHO cells with an expression vector capable of expressing the encoded recombinant glycoprotein; and

b) culturing the CHO cells of step (a) in cell culture medium under suitable conditions to express the recombinant glycoprotein,

wherein the cell culture medium comprises at least 100 mg/ml of zinc, about 0.1 g/L aspartic acid, about 0.1 g/L phosphate;

wherein the cell culture medium is maintained under following conditions:

i) pH between 6.5-7.5;

ii) dissolved oxygen between 5% and 90% of air saturation;

iii) carbon dioxide between 10 mmHg and 150 mmHg; and

iv) temperature between 30° C. and 37° C.; and

wherein the sialic content of the recombinant glycoprotein is increased.

2. The method of claim 1 , wherein the cell culture medium is chemically defined.

3. The method of claim 2 , wherein the chemically defined cell culture medium is basal medium.

4. The method of claim 3 , wherein the chemically defined basal medium does not contain added serum or hydrolysates.

5. The method of claim 3 , wherein the chemically defined basal medium is protein-free.

6. The process according to claim 1 , wherein the glycoprotein is a recombinant antibody, antibody fragment or fusion protein.

Continuity (3)
Division 15774138
Provisional Application 62252849 · Nov 9, 2015
Related Publication 20220396776A1 · Dec 15, 2022
Cited By (1)
US 12,234,483